Terms: = Breast cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
56 results:
1. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
2. Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.
Wiedemann C; Kazdal D; Cvetkovic J; Kunz J; Fisch D; Kirchner M; Kriegsmann M; Sültmann H; Heussel CP; Bischoff H; Thomas M; Stenzinger A; Christopoulos P
Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36207130
[TBL] [Abstract] [Full Text] [Related]
3. tnfaip3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway.
Feng W; Gao M; Yang M; Li X; Gan Z; Wu T; Lin Y; He T
Med Oncol; 2022 Sep; 39(12):230. PubMed ID: 36175778
[TBL] [Abstract] [Full Text] [Related]
4. tnfaip3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion.
Gao M; Li X; Yang M; Feng W; Lin Y; He T
Clin Transl Oncol; 2022 Dec; 24(12):2453-2465. PubMed ID: 36002765
[TBL] [Abstract] [Full Text] [Related]
5. Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and tnfaip3 Axis to Induce Apoptosis in breast cancer Cells.
Park JE; Ji HW; Kim HW; Baek M; Jung S; Kim SJ
Am J Chin Med; 2022; 50(6):1703-1717. PubMed ID: 35787669
[TBL] [Abstract] [Full Text] [Related]
6. Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role.
Mulla SW; Venkatraman P
Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311
[TBL] [Abstract] [Full Text] [Related]
7. The
Song C; Kendi AT; Lowe VJ; Lee S
Anticancer Res; 2022 Feb; 42(2):681-695. PubMed ID: 35093867
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian cancer.
Han GH; Hwang I; Cho H; Ylaya K; Choi JA; Kwon H; Chung JY; Hewitt SM; Kim JH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071938
[TBL] [Abstract] [Full Text] [Related]
9. Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5
Davies JA; Marlow G; Uusi-Kerttula HK; Seaton G; Piggott L; Badder LM; Clarkson RWE; Chester JD; Parker AL
Viruses; 2021 May; 13(5):. PubMed ID: 34066836
[TBL] [Abstract] [Full Text] [Related]
10. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Tang J; Wu Z; Tian Z; Chen W; Wu G
Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
[TBL] [Abstract] [Full Text] [Related]
11. The dual roles of a20 in cancer.
Shi Y; Wang X; Wang J; Wang X; Zhou H; Zhang L
Cancer Lett; 2021 Jul; 511():26-35. PubMed ID: 33933552
[TBL] [Abstract] [Full Text] [Related]
12. Screening of osteoarthritis diagnostic markers based on immune-related genes and immune infiltration.
Yuan WH; Xie QQ; Wang KP; Shen W; Feng XF; Liu Z; Shi JT; Zhang XB; Zhang K; Deng YJ; Zhou HY
Sci Rep; 2021 Mar; 11(1):7032. PubMed ID: 33782454
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical Assessment of tnfaip3/a20 Expression Correlates With Early Tumorigenesis in breast cancer.
Sharif-Askari FS; Al-Khayyal N; Talaat I; Sharif-Askari NS; Rawat S; Jundi M; SyrjÄnen K; Hamoudi R; Bendardaf R
Anticancer Res; 2021 Feb; 41(2):739-745. PubMed ID: 33517278
[TBL] [Abstract] [Full Text] [Related]
14. Combined a20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Pathol Int; 2021 Jan; 71(1):60-69. PubMed ID: 33159706
[TBL] [Abstract] [Full Text] [Related]
15. High a20 expression negatively impacts survival in patients with breast cancer.
Yoon CI; Ahn SG; Bae SJ; Shin YJ; Cha C; Park SE; Lee JH; Ooshima A; Lee HS; Yang KM; Kim SJ; Park SH; Jeong J
PLoS One; 2019; 14(8):e0221721. PubMed ID: 31449546
[TBL] [Abstract] [Full Text] [Related]
16. Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Thomas S; Kuncheria L; Roulstone V; Kyula JN; Mansfield D; Bommareddy PK; Smith H; Kaufman HL; Harrington KJ; Coffin RS
J Immunother Cancer; 2019 Aug; 7(1):214. PubMed ID: 31399043
[TBL] [Abstract] [Full Text] [Related]
17. EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy.
Kapp K; Volz B; Curran MA; Oswald D; Wittig B; Schmidt M
J Immunother Cancer; 2019 Jan; 7(1):5. PubMed ID: 30621769
[TBL] [Abstract] [Full Text] [Related]
18. The pleiotropic effects of TNFα in breast cancer subtypes is regulated by tnfaip3/a20.
Lee E; Ouzounova M; Piranlioglu R; Ma MT; Guzel M; Marasco D; Chadli A; Gestwicki JE; Cowell JK; Wicha MS; Hassan KA; Korkaya H
Oncogene; 2019 Jan; 38(4):469-482. PubMed ID: 30166590
[TBL] [Abstract] [Full Text] [Related]
19. tnfaip3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract] [Full Text] [Related]
20. Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.
Mazzio EA; Lewis CA; Elhag R; Soliman KF
Cancer Genomics Proteomics; 2018; 15(4):249-264. PubMed ID: 29976630
[TBL] [Abstract] [Full Text] [Related]
[Next]
